PMGC Holdings shares are trading higher after the company announced its subsidiary, NorthStrive Biosciences, signed a licensing agreement amendment with MOA Life that updates the timing and key development milestones for EL-32 and EL-22 human clinical development program. - PMGC Holdings (NASDAQ:ELAB)
Published on March 27, 2026.
The announcement of a licensing agreement amendment with the company's subsidiary, NorthStrive Biosciences, changes the timing and key development milestones for the EL-32 and the 22nd human clinical development program. The company's shares have surged following the announcement of the amendment.
Related Articles
James City County proposes $413.1 million budget that includes 3-cent real estate tax rate cut
James City County proposes a $413.1 million fiscal year 2027 budget with a 3-cent real estate tax cut and a 2% meals tax increase.
UWM Holdings Issues Statement Regarding Its Proposal to Acquire TWO - UWM Holdings (NYSE:UWMC)
U.S.E.O.R.O.,E.S.,E.,R.S;
Bitcoin Traders Bet On Sub-$66K BTC In April Due To Rising Fear
A rising fear and uncertainty are driving Bitcoin below $66,000 in options, with a 53% chance of staying below this level by April 24.